Glioma cell-derived EVs taken up by astrocytes increase their migratory capacity and activate oncogenic signaling pathways such as epidermal growth factor (EGF) and mitogen-activated protein kinase (MAPK) [135]. The gene discussed is EGF; the disease is central nervous system cancer.